106 related articles for article (PubMed ID: 30911975)
1. Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.
Pierce CE; de Vries ST; Bodin-Parssinen S; Härmark L; Tregunno P; Lewis DJ; Maskell S; Van Eemeren R; Ptaszynska-Neophytou A; Newbould V; Dasgupta N; Wisniewski AFZ; Gama S; Mol PGM
Drug Saf; 2019 Apr; 42(4):477-489. PubMed ID: 30911975
[TBL] [Abstract][Full Text] [Related]
2. Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients.
de Vries ST; Denig P; Lasheras Ruiz C; Houÿez F; Wong L; Sutcliffe A; Mol PGM;
Drug Saf; 2018 Jul; 41(7):697-712. PubMed ID: 29500800
[TBL] [Abstract][Full Text] [Related]
3. Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project.
Richardson JL; Moore A; Bromley RL; Stellfeld M; Geissbühler Y; Bluett-Duncan M; Winterfeld U; Favre G; Alexe A; Oliver AM; van Rijt-Weetink YRJ; Hodson KK; Rezaallah B; van Puijenbroek EP; Lewis DJ; Yates LM
Drug Saf; 2023 May; 46(5):479-491. PubMed ID: 36976447
[TBL] [Abstract][Full Text] [Related]
4. Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Kachikis A; Eckert LO; Walker C; Oteng-Ntim E; Guggilla R; Gupta M; Patwardhan M; Mataya R; Mallett Moore T; Alguacil-Ramos AM; Keech C; Gravett M; Murphy H; Kochhar S; Chescheir N;
Vaccine; 2017 Dec; 35(48 Pt A):6555-6562. PubMed ID: 29150061
[No Abstract] [Full Text] [Related]
5. Safety assessment of immunization in pregnancy.
Kochhar S; Bauwens J; Bonhoeffer J;
Vaccine; 2017 Dec; 35(48 Pt A):6469-6471. PubMed ID: 29031696
[No Abstract] [Full Text] [Related]
6. Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR.
van Stekelenborg J; Ellenius J; Maskell S; Bergvall T; Caster O; Dasgupta N; Dietrich J; Gama S; Lewis D; Newbould V; Brosch S; Pierce CE; Powell G; Ptaszyńska-Neophytou A; Wiśniewski AFZ; Tregunno P; Norén GN; Pirmohamed M
Drug Saf; 2019 Dec; 42(12):1393-1407. PubMed ID: 31446567
[TBL] [Abstract][Full Text] [Related]
7. Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria.
Elemuwa UG; Bitrus F; Oreagba IA; Osakwe AI; Abiodun AS; Onu K; Abubakar A; Faniyi AE; Etuk V; Yuah D; Momodu R; Adeyeye CM
Pharmaceut Med; 2024 May; 38(3):251-259. PubMed ID: 38705932
[TBL] [Abstract][Full Text] [Related]
8. Digital Technology Applications in the Management of Adverse Drug Reactions: Bibliometric Analysis.
Litvinova O; Yeung AWK; Hammerle FP; Mickael ME; Matin M; Kletecka-Pulker M; Atanasov AG; Willschke H
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543181
[TBL] [Abstract][Full Text] [Related]
9. Development of a Web-Based System to Report Medication-Related Adverse Effects: Design and Usability Study.
Lim R; Thornton C; Stanek J; Ellett LK; Thiessen M
JMIR Form Res; 2022 Oct; 6(10):e37605. PubMed ID: 36206034
[TBL] [Abstract][Full Text] [Related]
10. Mobile apps for quick adverse drug reaction report: A scoping review.
Parracha ER; Advinha AM; Lopes MJ; Oliveira-Martins S
Pharmacoepidemiol Drug Saf; 2023 Jan; 32(1):19-27. PubMed ID: 36125022
[TBL] [Abstract][Full Text] [Related]
11. The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017-2022.
Hallinan CM; Bonomo YA
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011488
[TBL] [Abstract][Full Text] [Related]
12. A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction Monitoring: Development and Usability Study.
Di Filippo M; Avellone A; Belingheri M; Paladino ME; Riva MA; Zambon A; Pescini D
JMIR Hum Factors; 2022 Nov; 9(4):e38701. PubMed ID: 35930561
[TBL] [Abstract][Full Text] [Related]
13. Developing a Mobile Health Application to Communicate Adverse Drug Reactions - Preconditions, Assessment of Possible Functionalities and Barriers for Patients and Their General Practitioners.
Wakob I; Schmid GL; Nöhring I; Elze R; Sultzer R; Frese T; Schiek S; Bertsche T
J Multidiscip Healthc; 2022; 15():1445-1455. PubMed ID: 35837350
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial.
Kiguba R; Mwebaza N; Ssenyonga R; Ndagije HB; Nambasa V; Katureebe C; Katumba K; Tregunno P; Harrison K; Karamagi C; Scott KA; Pirmohamed M
BMJ Open; 2022 Jul; 12(7):e061725. PubMed ID: 35777873
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a peer support intervention to promote the detection, reporting and management of adverse drug reactions in people living with HIV in Uganda: a protocol for a quasi-experimental study.
Kiguba R; Ndagije HB; Nambasa V; Katureebe C; Zakumumpa H; Nanyonga SM; Ssanyu JN; Tregunno P; Harrison K; Merle CS; Raguenaud ME; Kitutu FE
BMJ Open; 2022 May; 12(5):e056039. PubMed ID: 35589351
[TBL] [Abstract][Full Text] [Related]
16. Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience.
Fukushima A; Iessa N; Balakrishnan MR; Pal SN
BMC Med Inform Decis Mak; 2022 May; 22(1):118. PubMed ID: 35501745
[TBL] [Abstract][Full Text] [Related]
17. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies.
Thanarajasingam G; Minasian LM; Bhatnagar V; Cavalli F; De Claro RA; Dueck AC; El-Galaly TC; Everest N; Geissler J; Gisselbrecht C; Gormley N; Gribben J; Horowitz M; Ivy SP; Jacobson CA; Keating A; Kluetz PG; Kwong YL; Little RF; Matasar MJ; Mateos MV; McCullough K; Miller RS; Mohty M; Moreau P; Morton LM; Nagai S; Nair A; Nastoupil L; Robertson K; Sidana S; Smedby KE; Sonneveld P; Tzogani K; van Leeuwen FE; Velikova G; Villa D; Wingard JR; Seymour JF; Habermann TM
Lancet Haematol; 2022 May; 9(5):e374-e384. PubMed ID: 35483398
[TBL] [Abstract][Full Text] [Related]
18. Factors that influence the intention to use mobile phone caller tunes for patient reporting of adverse drug reactions: a qualitative study.
Appiah B; Poudyal A; Burdine JN; Asamoah-Akuoko L; Anum DA; Kretchy IA; Sabblah G; Dodoo ANO; McKyer ELJ
Ther Adv Drug Saf; 2019; 10():2042098619871190. PubMed ID: 35173950
[TBL] [Abstract][Full Text] [Related]
19. Teaching Pharmacovigilance to Healthcare Students: Identifying Gaps and Opportunities for Improvement.
Seselja Perisin A; Bukic J; Rusic D; Leskur D; Bozic J; Mihanovic A; Vilovic M; Cohadzic T; Modun D
Pharmacy (Basel); 2021 Aug; 9(3):. PubMed ID: 34449747
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
